[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2885004T3 - Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol - Google Patents

Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol

Info

Publication number
PL2885004T3
PL2885004T3 PL13756009T PL13756009T PL2885004T3 PL 2885004 T3 PL2885004 T3 PL 2885004T3 PL 13756009 T PL13756009 T PL 13756009T PL 13756009 T PL13756009 T PL 13756009T PL 2885004 T3 PL2885004 T3 PL 2885004T3
Authority
PL
Poland
Prior art keywords
dihydroquercetin
bisabolol
tocopherol
alpha
composition
Prior art date
Application number
PL13756009T
Other languages
English (en)
Inventor
Christian Auclair
Original Assignee
Bionoox Suisse Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionoox Suisse Sa filed Critical Bionoox Suisse Sa
Publication of PL2885004T3 publication Critical patent/PL2885004T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13756009T 2012-08-20 2013-08-20 Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol PL2885004T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12181058.4A EP2700413B1 (en) 2012-08-20 2012-08-20 Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
EP13756009.0A EP2885004B1 (en) 2012-08-20 2013-08-20 Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol

Publications (1)

Publication Number Publication Date
PL2885004T3 true PL2885004T3 (pl) 2017-06-30

Family

ID=46832228

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13756009T PL2885004T3 (pl) 2012-08-20 2013-08-20 Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol

Country Status (8)

Country Link
US (1) US9271956B2 (pl)
EP (2) EP2700413B1 (pl)
JP (1) JP6298819B2 (pl)
CA (1) CA2883348C (pl)
ES (2) ES2559454T3 (pl)
HK (1) HK1205954A1 (pl)
PL (1) PL2885004T3 (pl)
WO (1) WO2014029780A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2907513A1 (en) * 2014-02-18 2015-08-19 Bionoox Suisse SA Compositions comprising dihydroquercetin for use in methods for alleviating the effects associated with skin inflammatory disorders
AU2015243819B2 (en) 2014-04-07 2019-08-29 Interdigital Ce Patent Holdings Method of controlling handover in mobile communication networks and apparatus and system implementing the method
EP3270901B1 (en) * 2015-03-18 2021-01-20 Bionoox Suisse SA Compositions comprising dihydroquercetin for use in methods for treating herpes
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
CA3085013A1 (en) 2017-12-13 2019-06-20 Onquality Pharmaceuticals China Ltd. A method for preventing or treating egfr-inhibition associated diseases
EP3520818A1 (en) * 2018-02-01 2019-08-07 AC BioScience SA Compositions for treating and /or preventing photodynamic therapy side effects
KR20200144116A (ko) 2018-04-16 2020-12-28 온퀄리티 파마슈티컬스 차이나 리미티드 암 치료의 부작용을 예방하거나 치료하기 위한 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3226700B2 (ja) * 1994-02-07 2001-11-05 丸善製薬株式会社 美白剤および皮膚外用剤
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
DE10055469A1 (de) * 2000-11-09 2002-05-23 Merck Patent Gmbh Konjugat, dessen Herstellung und Verwendung
GB2380003A (en) 2001-07-03 2003-03-26 Digital Comm Technologies Ltd Method and apparatus for executing stack based programs using a register based processor
US20030105027A1 (en) 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
DE102004007966A1 (de) 2004-02-18 2005-09-08 Merck Patent Gmbh Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol
EP1791514B1 (en) * 2004-09-24 2010-04-14 Gelicity (UK) Limited Exfoliating and softening composition
RU2382635C1 (ru) * 2008-10-29 2010-02-27 Открытое Акционерное Общество "Институт пластической хирургии и косметологии" Крем для рук
FR2963556A3 (fr) * 2010-08-03 2012-02-10 Sephar Soc D Etudes Pharma Nouvelle composition pharmaceutique et cosmetique et ses applications dans les corrections des troubles de la microcirculation sanguine et des reactions inflammatoires pour des epidermes deshydrates

Also Published As

Publication number Publication date
CA2883348C (en) 2021-01-12
CA2883348A1 (en) 2014-02-27
US20150238459A1 (en) 2015-08-27
EP2700413A1 (en) 2014-02-26
EP2700413B1 (en) 2015-10-14
JP6298819B2 (ja) 2018-03-20
JP2015525803A (ja) 2015-09-07
EP2885004A1 (en) 2015-06-24
HK1205954A1 (en) 2015-12-31
US9271956B2 (en) 2016-03-01
ES2559454T3 (es) 2016-02-12
WO2014029780A1 (en) 2014-02-27
EP2885004B1 (en) 2016-10-19
ES2610754T3 (es) 2017-05-03

Similar Documents

Publication Publication Date Title
IL238958A0 (en) Glutamase inhibitors, preparations containing them and their uses
IL238959A (en) Glutamase suppressors, preparations containing them and their uses
GB201318361D0 (en) Content protection
IL233824A (en) Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
HK1212156A1 (en) Antimicrobial composition
PL2885004T3 (pl) Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol
IL236712A0 (en) Di-teri-heteroaryl derivatives, preparations containing them and their uses
HK1210711A1 (en) Pharmaceutical composition comprising rebamipide
HK1204947A1 (en) Sterilized composition
EP2867307A4 (en) COMPOSITION CONTAINING SILVER
IL233682A0 (en) Modified phenylazole derivatives, preparations containing them and their uses
IL237542B (en) Amphiphilic compounds, their preparations and uses
IL280316B (en) Amphiphilic compounds, preparations and their use
ZA201502703B (en) Novel flavonoid compounds and uses thereof
IL237540B (en) Amphiphilic compounds, their preparations and uses
EP2934593A4 (en) COMPOSITION OF CABAZITAXEL
IL237538A0 (en) Amphiphilic compounds, their preparations and uses
IL237539A0 (en) Amphiphilic compounds, their preparations and uses
ZA201408903B (en) Antimicrobial composition
IL235312A0 (en) Taxane compounds, preparations and methods
RS56379B1 (sr) Kompozicija za zaštitu i uravnotežavanje kože